image
REGENXBIO Inc. RGNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.67
12.3 %
$ 334 M
Market Cap
-1.45
P/E
Price Target Average
366.64%
Revenue Forecast Estimate
74.68%
EBIT Estimate
--22.08%
Net Income Estimate
23.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets REGENXBIO Inc.
image
Wall Street analysts predict an average 1-year price target for RGNX of $31.1 , with forecasts ranging from a low of $18 to a high of $40 .
RGNX Lowest Price Target Wall Street Target
18 USD 169.87%
RGNX Average Price Target Wall Street Target
31.1 USD 366.64%
RGNX Highest Price Target Wall Street Target
40 USD 499.70%
Price
Max Price Target
Min Price Target
Average Price Target
404035353030252520201515101055Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart RGNX

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RGNX

image
$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RGNX

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029